Insight Molecular Diagnostics Inc., (NASDAQ: IMDX) shares enjoyed strong gains at first Monday, on providing a year-end business update regarding its commercial progress, its GraftAssureDx™ test kit ...

GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...

Insight Molecular Diagnostics (IMDX) provided a year-end business update regarding its commercial progress, its GraftAssureDx test kit clinical ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...

Nutriband shares are trading higher Monday after the company it signed an agreement to sell the majority stake of its ...

GRI Bio ( (GRI)) has shared an update. On December 11, 2025, GRI Bio, Inc. initiated a public offering involving shares of common stock, pre-funded warrants, and Series F warrants, aiming to raise ...

Jarez Holz says 2026 will be a strong year for biotech stocks. The Mizuho analyst explained why in a recent CNBC interview.

Radiopharm Theranostics Limited (NASDAQ: RADX) stock is trading higher on Monday, with a session volume of 21.33 million compared to the average volume of 26.81 thousand, as per data from Benzinga Pro ...

More than 900 jobs are coming to Montgomery County with a $90.2 million investment as T.RAD auto parts manufacturer comes to Clarksville-Montgomery County Corporate Business Park. The Clarksville ...

Vor Biopharma (VOR) rose ~17% on Tuesday after J.P. Morgan initiated its coverage with an Overweight recommendation and a Dec. 2026 price target of $43, citing a potential blockbuster status for the ...

Agentic AI Platform Transitions from Industry Trials to Live Invoicing as RAD-G Sets the Pace for the Monitoring Sector Detroit, Michigan, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Artificial Intelligence ...

Ariel Investments’ 13F portfolio rose to $9.35B in Q3 2025, with 38 core holdings exceeding 1% each. Learn more about the ...